StockData
U S Physical Therapy Inc logo

U S Physical Therapy Inc (USPH) stock analysis

USPHNYSEServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3022% above fair value
$100.10+0.86 (+0.87%)

Close on Nov 11, 2026Market cap $1.49BP/E –Yield 1.80%

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth2Performance3Health2Dividend1

Mixed9 of 30 checks passed

U S Physical Therapy passes 9 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
2/6
Past performance
3/6
Financial health
2/6
Dividend
1/6

What stands out

  • Earnings grew over 5 years

    Net income grew 2.4% a year on average over the last five fiscal years.

  • Revenue growing 10%+ a year

    Revenue grew 12.2% a year over the last three fiscal years.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 36.1% of total debt.

  • P/B below the industry

    U S Physical Therapy's price-to-book of 3.48 is below the Health Services median of 3.52.

What to watch

  • Margin of safety under 20%

    The price is 22.0% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $100.10 is above our fair value estimate of $82.03.

  • Return on equity under 15%

    Return on equity was 6.5% over the last twelve months and averaged 9.3% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 9.1%, below the 10% that usually covers the cost of capital.

Valuation1/6
  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA above its 5-year median

    U S Physical Therapy's EV/EBITDA of 17.3 is above its 5-year median of 16.0.

  • P/B below the industry

    U S Physical Therapy's price-to-book of 3.48 is below the Health Services median of 3.52.

  • Trading above fair value

    The share price of $100.10 is above our fair value estimate of $82.03.

  • Margin of safety under 20%

    The price is 22.0% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing 10%+ a year

    Revenue grew 12.2% a year over the last three fiscal years.

  • EPS growing under 10% a year

    Diluted EPS grew -14.2% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -32.5% over the last twelve months, against a 5-year average of 2.4% a year.

  • Growing slower than the industry

    Revenue grew 10.4% over the last twelve months; the Health Services median is 17.6%.

  • Guidance unchanged

    The latest outlook (full year 2026 adjusted EBITDA, Aug 6, 2026) was maintained, so it neither adds nor takes away points.

  • Gross margin improving

    Gross margin was 18.8% over the last twelve months, against 18.7% a year earlier.

Past performance3/6
  • Return on equity under 15%

    Return on equity was 6.5% over the last twelve months and averaged 9.3% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 9.1%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    U S Physical Therapy's return on equity of 6.5% is above the Health Services median of -1.1%.

  • Earnings grew over 5 years

    Net income grew 2.4% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 3.6% over the last twelve months, against a 5-year average of 5.7%.

  • Net margin above the industry

    U S Physical Therapy's net margin of 3.6% is above the Health Services median of -13.7%.

Financial health2/6
  • High debt

    Debt is 57.3% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 7.8% five years ago to 57.3%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 36.1% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets cover short-term debts

    Current assets are 1.42 times current liabilities.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.85; above 3 is the safe zone and below 1.8 the distress zone.

Dividend1/6
  • Pays a dividend

    U S Physical Therapy paid dividends worth 1.8% of the share price over the last twelve months.

  • Yield below Treasuries

    The 1.8% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; U S Physical Therapy yields 1.8%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Earnings cover

    Needs dividends paid and net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$82.03

The share price is 22% above this estimate.

20%+ below
Near fair value
20%+ above
$100.10Price$82.03Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
EV/EBITDA16.1×16.0×16.2×$92.0658%
P/B3.2×2.8×3.5×$91.1217%
Earnings power8.5% cost of equity––$52.5825%
Fair value$82.03100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 37.8
  • Health Services median 23.9

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$16.79M
Value traded per 1% price move
$11.94M

Downside

Medium risk

Typical loss in a bad month
19.6%
Volatility (annualized)
38%
Sharpe ratio, 1 year
0.85
Beta to the S&P 500 (5Y)
0.72

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

19.2%−3.2 pts over 5 years

Operating margin

11.1%−1.3 pts over 5 years

Net margin

5.1%−3.3 pts over 5 years

See a number that looks wrong?